Wikipedia -WSS

Wikipedia

author：explore 2025-09-28 01:35:41 - browse：84786

Frank Pallone -- health policy coverage from STAT — Rep. Frank Pallone (D-N.J.) J. Scott Applewhite/AP

WASHINGTON — A Democrat has signed on to a legislative package that would require health care transparency by law and enact modest payment reforms to pharmacy middlemen and hospitals, increasing its chances of passing the House of Representatives.

Republicans conceded to a few tweaks to the legislation to ensure that transparency regulations for hospitals were at least equal to current regulations, which gained the endorsement of House Energy and Commerce Committee ranking member Frank Pallone (D-N.J.).

Two other prominent Democrats on relevant committees didn’t sign on: Rep. Richard Neal (D-Mass.), who had voiced concerns about the bill’s lack of transparency provisions requiring disclosure of private equity ownership, and Rep. Bobby Scott (D-Va.).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Roivant's CEO is a star, but biotech's black hole persists

WSS

STAT Summit: Meghan O’Rourke on making chronic illness visible

Risky weight loss products often used by teens globally, per study

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Is there really a nursing shortage in the U.S.?

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

UnitedHealth, Optum discontinue NaviHealth name

hotspot

Wikipedia

focus

Walensky prepares to leave CDC — and Congress — behind

STAT Readout: Friday, Oct. 20 biotech updates

In age of alternative facts, a scholarly course on calling out crap

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Psychedelics group wrestles with new pharma identity

New England Journal of Medicine addresses racist history, slavery

Tori Bowie and the unacceptable rates of Black maternal death

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Psychedelics group wrestles with new pharma identity

New Medicare drug pricing powers could soon be upended in court

hotspot

UnitedHealth, Optum discontinue NaviHealth name

Health tech investors get more selective as pandemic boom fades

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Fauci’s Covid grilling leads GOP to weigh foreign research rules

New Medicare drug pricing powers could soon be upended in court

Readout LOUD podcast: Live from the 2023 STAT Summit

explore

hotspot

Wikipedia

Wikipedia